Comparison of the glucagon-like-peptide-1 receptor agonists dulaglutide and liraglutide for the management of diabetes in solid organ transplant: A retrospective study.

Diabetes Obes Metab · 2020 · PMC9292640 · PMID 31943645

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In the dulaglutide group, renal function not only remained stable but also showed a trend towards improvement despite the advanced CKD; however, in the liraglutide group, there was a trend towards worsening renal function.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.